Repertoire Partners LP Has $2.97 Million Holdings in Integral Ad Science Holding Corp. (NASDAQ:IAS)

Repertoire Partners LP increased its holdings in shares of Integral Ad Science Holding Corp. (NASDAQ:IAS - Free Report) by 83.7% in the 4th quarter, according to its most recent filing with the SEC. The fund owned 284,707 shares of the company's stock after purchasing an additional 129,707 shares during the period. Integral Ad Science makes up approximately 1.2% of Repertoire Partners LP's holdings, making the stock its 5th largest position. Repertoire Partners LP owned 0.18% of Integral Ad Science worth $2,972,000 at the end of the most recent quarter.

Several other hedge funds have also recently added to or reduced their stakes in IAS. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its stake in Integral Ad Science by 4.6% in the fourth quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 41,519 shares of the company's stock valued at $433,000 after acquiring an additional 1,832 shares during the period. Jennison Associates LLC lifted its position in shares of Integral Ad Science by 3.3% during the fourth quarter. Jennison Associates LLC now owns 63,538 shares of the company's stock worth $663,000 after purchasing an additional 2,046 shares in the last quarter. Oppenheimer & Co. Inc. raised its position in Integral Ad Science by 8.0% in the 4th quarter. Oppenheimer & Co. Inc. now owns 28,040 shares of the company's stock worth $293,000 after purchasing an additional 2,069 shares during the last quarter. Envestnet Asset Management Inc. lifted its holdings in Integral Ad Science by 7.4% during the 4th quarter. Envestnet Asset Management Inc. now owns 31,807 shares of the company's stock worth $332,000 after buying an additional 2,188 shares in the last quarter. Finally, Arizona State Retirement System lifted its holdings in Integral Ad Science by 12.5% during the 4th quarter. Arizona State Retirement System now owns 23,404 shares of the company's stock worth $244,000 after buying an additional 2,601 shares in the last quarter. Institutional investors own 95.78% of the company's stock.

Wall Street Analyst Weigh In

IAS has been the topic of several research reports. Wall Street Zen lowered Integral Ad Science from a "buy" rating to a "hold" rating in a research note on Thursday. Truist Financial increased their price objective on shares of Integral Ad Science from $16.00 to $17.00 and gave the company a "buy" rating in a report on Monday, March 3rd. Stifel Nicolaus dropped their target price on shares of Integral Ad Science from $15.00 to $13.00 and set a "buy" rating for the company in a research report on Wednesday, April 23rd. Raymond James increased their price target on shares of Integral Ad Science from $11.00 to $13.00 and gave the company an "outperform" rating in a research report on Tuesday, May 13th. Finally, Morgan Stanley lowered their target price on Integral Ad Science from $13.50 to $12.50 and set an "equal weight" rating for the company in a research note on Thursday, April 17th. Seven analysts have rated the stock with a hold rating and six have issued a buy rating to the company's stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of "Hold" and a consensus price target of $13.55.

Integral Ad Science Stock Down 2.0%

Shares of NASDAQ:IAS traded down $0.16 during midday trading on Monday, reaching $7.84. The company had a trading volume of 1,562,967 shares, compared to its average volume of 1,016,129. Integral Ad Science Holding Corp. has a 1-year low of $6.26 and a 1-year high of $13.62. The stock has a market cap of $1.29 billion, a PE ratio of 39.20, a P/E/G ratio of 1.06 and a beta of 1.55. The company has a quick ratio of 3.71, a current ratio of 3.71 and a debt-to-equity ratio of 0.07. The business's 50 day moving average price is $7.55 and its 200 day moving average price is $9.46.

Integral Ad Science (NASDAQ:IAS - Get Free Report) last posted its quarterly earnings results on Monday, May 12th. The company reported $0.05 earnings per share for the quarter, topping the consensus estimate of $0.03 by $0.02. The firm had revenue of $134.07 million for the quarter, compared to analyst estimates of $129.20 million. Integral Ad Science had a return on equity of 3.47% and a net margin of 6.39%. Research analysts forecast that Integral Ad Science Holding Corp. will post 0.26 EPS for the current fiscal year.

Insider Buying and Selling at Integral Ad Science

In other Integral Ad Science news, CEO Lisa Utzschneider sold 68,671 shares of the stock in a transaction dated Thursday, April 3rd. The shares were sold at an average price of $7.44, for a total value of $510,912.24. Following the transaction, the chief executive officer now directly owns 334,051 shares of the company's stock, valued at $2,485,339.44. This represents a 17.05% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Insiders have sold 86,222 shares of company stock worth $636,252 over the last 90 days. Company insiders own 2.00% of the company's stock.

Integral Ad Science Profile

Integral Ad Science Holding Corp. operates as a digital advertising verification company in the United States, the United Kingdom, France, Ireland, Germany, Italy, Singapore, Australia, Japan, India, and the Nordics. The company provides IAS Signal, a cloud-based technology platform that offers return on ad spend needs; and deliver independent measurement and verification of digital advertising across devices, channels, and formats, including desktop, mobile, connected TV, social, display, and video.